Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target

Cryptococcus remains a leading cause of invasive fungal infections in immunocompromised people. Resistance to azole drugs has imposed a further challenge to the effective treatment of such infections. In this study, the functional expression of full-length hexahistidine-tagged Cryptococcus neoforman...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruma, Yasmeen N., Keniya, Mikhail V., Monk, Brian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785471/
https://www.ncbi.nlm.nih.gov/pubmed/36547589
http://dx.doi.org/10.3390/jof8121256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785471/
https://www.ncbi.nlm.nih.gov/pubmed/36547589
http://dx.doi.org/10.3390/jof8121256

Ejemplares similares